These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6402702)

  • 21. Abnormal alanine aminotransferase level in blood units from donors in Montreal does not indicate high risk of transmitting hepatitis.
    Steinbrecher UP; Kovacs TO; Gelly A; Tourigny M
    Clin Invest Med; 1983; 6(4):327-30. PubMed ID: 6671363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-transfusion viral hepatitis and the TTVS.
    Holland PV; Bancroft W; Zimmerman H
    N Engl J Med; 1981 Apr; 304(17):1033-5. PubMed ID: 6782483
    [No Abstract]   [Full Text] [Related]  

  • 23. Strategies for the prevention of post-transfusion hepatitis.
    Mintz PD
    Ann Clin Lab Sci; 1984; 14(3):198-207. PubMed ID: 6428295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
    Alter HJ; Purcell RH; Shih JW; Melpolder JC; Houghton M; Choo QL; Kuo G
    N Engl J Med; 1989 Nov; 321(22):1494-500. PubMed ID: 2509915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention of post-transfusion hepatitis non-A, non-B. Report established by the National Agency for the Development of Medical Evaluation on demand of the General Health Direction].
    Gayno S
    Gastroenterol Clin Biol; 1991; 15(8-9):667-8. PubMed ID: 1752387
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Post-transfusional non-A, non-B hepatitis].
    Habibi
    Bull Soc Sci Med Grand Duche Luxemb; 1988; 125(2):63-70. PubMed ID: 3149551
    [No Abstract]   [Full Text] [Related]  

  • 28. Current status of posttransfusion hepatitis.
    Alter HJ; Holland PV; Purcell RH
    Pathobiol Annu; 1980; 10():135-56. PubMed ID: 6777742
    [No Abstract]   [Full Text] [Related]  

  • 29. Donor transaminase and recipient hepatitis. Impact on blood transfusion services.
    Alter HJ; Purcell RH; Holland PV; Alling DW; Koziol DE
    JAMA; 1981 Aug; 246(6):630-4. PubMed ID: 6788964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Contribution to the task of reducing the incidence of post transfusion non-A, non-B hepatitis].
    Hernández Sánchez MC; Vila Enriquez P; Alvarez Hernández M
    Sangre (Barc); 1989 Jun; 34(3):248-9. PubMed ID: 2503897
    [No Abstract]   [Full Text] [Related]  

  • 31. [Transmission of hepatitis by transfusion].
    Fiser-Herman M; Polak A
    Lijec Vjesn; 1970; 92(5):545-53. PubMed ID: 5205536
    [No Abstract]   [Full Text] [Related]  

  • 32. Measurement of alanine aminotransferase (ALT) levels in Zimbabwean donor serum--a possible indicator of non-A, non-B hepatitis.
    Emmanuel JC; Bassett MT; Smith HJ; Paterson LE
    Cent Afr J Med; 1989 Aug; 35(8):469-70. PubMed ID: 2509075
    [No Abstract]   [Full Text] [Related]  

  • 33. [Role of donors in the spread of viral hepatitis].
    Grinshtein EA; Aleinik MD; Altman RSh; Klimova NIa; Piskunova AV
    Sov Med; 1973 Mar; 36(3):129-32. PubMed ID: 4756447
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical aspects and risk factors in posttransfusion hepatitis].
    Realdi G; Tremolada F; Chiappetta F; Antona C; Noventa F; Loreggian M; Chemello L; Alberti A
    Ric Clin Lab; 1984; 14 Suppl 1():17-35. PubMed ID: 6330858
    [No Abstract]   [Full Text] [Related]  

  • 35. [Selection of donors in the prevention of post-transfusion viral hepatitis].
    Massaro AL
    Riv Emoter Immunoematol; 1985; 32(2):156-9. PubMed ID: 3937210
    [No Abstract]   [Full Text] [Related]  

  • 36. Transfusion-transmitted hepatitis virus infection.
    Dodd RY
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):137-54. PubMed ID: 7737938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Decrease of transfusion hepatitis following introduction of transaminases and Australia (SH)-antigen determination in blood donors].
    Arndt HJ; Frese R; Nachtwey K; Loos W; Kaboth U; Creutzfeldt W
    Dtsch Med Wochenschr; 1971 Aug; 96(34):1371-2. PubMed ID: 4998053
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevalence of type B and non-A, non-B hepatitis in hemophilia: relationship to chronic liver disease.
    Kim HC; Saidi P; Ackley AM; Bringelsen KA; Gocke DJ
    Gastroenterology; 1980 Dec; 79(6):1159-64. PubMed ID: 6777232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Post-transfusion hepatitis and the diagnosis of infectious hepatitis in donors (a review of the literature and the authors' own data)].
    Gromashevskaia LL; Khersonskaia RIa; Stroganov BV
    Probl Gematol Pereliv Krovi; 1973 Feb; 18(2):40-5. PubMed ID: 4587776
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hepatitis C and ALT in blood donors].
    García Bueno MJ
    Sangre (Barc); 1991 Jun; 36(3):252-3. PubMed ID: 1948551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.